Literature DB >> 9400993

High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.

H Kashiwazaki1, H Tonoki, M Tada, I Chiba, M Shindoh, Y Totsuka, R Iggo, T Moriuchi.   

Abstract

To determine the timing and actual incidence of p53 mutations in oral epithelial lesions, we examined 33 primary squamous cell carcinomas (SCCs), 14 dysplasias and six hyperplasias from Japanese patients by a combination of yeast functional assay and DNA sequencing. The assay detects mutations of p53 mRNA between codons 67 and 347 on the basis of the DNA-binding activity of the protein. Twenty-six SCCs (79%) and five dysplasias (36%) were positive for p53 mutation, while all six hyperplasias were negative for the mutation. Human papillomavirus type 16 E6 mRNA was detected in one of seven p53 mutation-negative SCCs by reverse transcription polymerase chain reaction (RT-PCR). We further examined p53 mutations in 17 Sri Lankan oral SCCs using the yeast functional assay and the single-strand conformation polymorphism analysis of PCR-amplified DNA fragments (PCR-SSCP) of exon 5-8. The mutations were confirmed by DNA sequencing and the detection sensitivity was compared between the two methods. Six samples (35%) were positive for p53 mutation in PCR-SSCP analysis, while nine samples (53%) were positive in yeast functional assay. This suggests that the incidence of p53 mutations has been considerably underestimated in the conventional SSCP analysis. The present data indicate that p53 mutations are extremely frequent in oral cancers in the Japanese, and suggest that the timing and significance of p53 mutation in oral tumor progression vary in different ethnic populations and areas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400993     DOI: 10.1038/sj.onc.1201438

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast.

Authors:  Jana Smardová; Sárka Pavlová; Hana Koukalová
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

Review 2.  Prevention of head and neck cancer.

Authors:  Terry A Day; Angela Chi; Brad Neville; James R Hebert
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

3.  Somatic mutations of the APC gene in primary breast cancers.

Authors:  K Furuuchi; M Tada; H Yamada; A Kataoka; N Furuuchi; J Hamada; M Takahashi; S Todo; T Moriuchi
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.

Authors:  I Cruz; S S Napier; I van der Waal; P J F Snijders; J M M Walboomers; P J Lamey; C G Cowan; T A Gregg; P Maxwell; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

5.  Development of a yeast stop codon assay readily and generally applicable to human genes.

Authors:  A Kataoka; M Tada; M Yano; K Furuuchi; S Cornain; J Hamada; G Suzuki; H Yamada; S Todo; T Moriuchi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

6.  Mutations in p53 Gene Exons in a Sample from the South of Spain in Oral Cancer.

Authors:  Guiomar Martín-Lozano; Raquel Gómez-Díaz; Fernando Iglesías-Martín; Daniel Torres-Lagares; Aida Gutiérrez-Corrales; José-Luis Gutiérrez-Pérez
Journal:  J Clin Exp Dent       Date:  2021-10-01

7.  The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.

Authors:  Dirk O Bauerschlag; Christian Schem; Marion T Weigel; Constantin Von Kaisenberg; Alexander Strauss; Thomas Bauknecht; Nicolai Maass; Ivo Meinhold-Heerlein
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

8.  p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients.

Authors:  H Bonnefoi; A Ducraux; S Movarekhi; M F Pelte; S Bongard; E Lurati; R Iggo
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

9.  Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.

Authors:  Walid Zedan; Mohamed I Mourad; Sherin M Abd El-Aziz; Nagla M Salamaa; Asem A Shalaby
Journal:  Diagn Pathol       Date:  2015-02-22       Impact factor: 2.644

10.  Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.

Authors:  Joe Matsumoto; Masako Kaneda; Mitsuhiro Tada; Jun-ichi Hamada; Shunichi Okushiba; Satoshi Kondo; Hiroyuki Katoh; Tetsuya Moriuchi
Journal:  Jpn J Cancer Res       Date:  2002-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.